Li She

Discovery of a Clinical Candidate from the Structurally Unique Dioxa-bicyclo[3.2.1]octane Class of Sodium-Dependent Glucose Cotransporter 2 Inhibitors

Vincent Mascitti, Tristan S. Maurer, Ralph P. Robinson et al. · Journal of Medicinal Chemistry · 2011 · 133 citations · Full text

Pharmaceutical Science, Clinical Candidate, Pharmacotherapy +16

Decreased visceral adiposity accounts for leptin effect on hepatic but not peripheral insulin action

Nir Barzilai, Li She, Lisen Liu et al. · American Journal of Physiology-Endocrinology and Metabolism · 1999 · 64 citations

Ability of insulin to modulate hepatic glucose production in aging rats is impaired by fat accumulation

Gaurav Gupta, Jane A. Cases, Li She et al. · American Journal of Physiology-Endocrinology and Metabolism · 2000 · 59 citations

PF-03882845, a non-steroidal mineralocorticoid receptor antagonist, prevents renal injury with reduced risk of hyperkalemia in an animal model of nephropathy

Stephen Orena, Tristan S. Maurer, Li She et al. · Frontiers in Pharmacology · 2013 · 52 citations · Full text

C-Aryl glycoside inhibitors of SGLT2: Exploration of sugar modifications including C-5 spirocyclization

Ralph P. Robinson, Vincent Mascitti, Carine M. Boustany‐Kari et al. · Bioorganic & Medicinal Chemistry Letters · 2010 · 43 citations · Full text

C-5 Spirocyclization, Sugar Modifications, Medicinal Chemistry +12